Purchase Order 75N92025P00382
Award Date 9/17/25
Potential Completion Date 9/16/26
Potential Value $65K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract was awarded to Illumina, Inc. by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to provide service and maintenance for autoloader and Tecan robot instruments. The contract has a ceiling value of $173,660.24 and a period of performance ending on September 16, 2025. The contract was not set aside for any specific business type. Illumina is a manufacturer and provider of sequencing and...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,613.88 firm fixed price delivery order to Illumina, Inc. under contract number QTE# 00015178.1. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is July 31, 2023 for genomic sequencing and analysis services to support the Institute's research efforts aimed at advancing the understanding of the human...
- The National Human Genome Research Institute (NHGRI) awarded a $84,051.50 firm fixed-price purchase order contract to Illumina, Inc. for an Illumina Autoloader2 Bronze Support, iScan Bronze Support, and Product Care LIHA Service Contract. The contract supports the Genomics Core lab's use of four Illumina iScan, Autoloader, and Tecan LiHa instruments in their genotyping services. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
- The National Human Genome Research Institute awarded a delivery order contract to Illumina, Inc. for Illumina reagents and consumables, effective through June 9, 2026. This firm fixed-price delivery order, valued at approximately $999K, was awarded on September 3, 2020, with no set-aside designation. The contract is performed in San Diego, California, where Illumina maintains its headquarters. As a specialized biotechnology manufacturer, Illumina supplies advanced genetic sequencing instruments,...
- Illumina, Inc. was awarded a delivery order valued at $47,502 by the National Human Genome Research Institute (NHGRI) on September 3, 2020, with an ultimate completion date of March 2, 2026. This firm fixed price contract, with no set-aside designation, supports the NHGRI's genomic research initiatives and leverages Illumina's specialized capabilities in genetic sequencing technologies. The work will be performed at Illumina's San Diego, California facility, where the company manufactures...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $195,464.40 contract provides for Illumina Sequencers Service Agreement, which includes the procurement of advanced sequencing instruments like NextSeq, NovaSeq, MiSeq, and iSeq systems, along with associated reagents,...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, an agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $12,103.44 contract has a completion date of September 29, 2025 and does not utilize a set-aside designation. Illumina provides a range of genomic sequencing platforms, reagents, consumables, and maintenance services to support...
- This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis instruments and reagents. The contract, valued at $204,056.23, is for a renewal maintenance agreement to keep the Illumina instruments used by the NIH's Genomics and Computational Biology Core operational and properly maintained. This sole-source contract was awarded without any set-aside designation. Illumina has...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $75,000 firm fixed price delivery order to Illumina, Inc. of San Diego, California on July 21, 2023. The order was placed under an unspecified government-wide acquisition contract vehicle to support the agency's genomic research efforts. Illumina will provide genomics products and services to the National Human Genome Research Institute to advance the institute's mission...